Skip to main content

Peer Review reports

From: Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer

Original Submission
29 Mar 2023 Submitted Original manuscript
7 Apr 2023 Author responded Author comments - Rui Hou
23 Apr 2023 Author responded Author comments - Rui Hou
Resubmission - Version 2
7 Apr 2023 Submitted Manuscript version 2
25 Apr 2023 Author responded Author comments - Rui Hou
Resubmission - Version 3
25 Apr 2023 Submitted Manuscript version 3
23 Jun 2023 Reviewed Reviewer Report
11 Jul 2023 Reviewed Reviewer Report - Dhifaf Sarhan
25 Jul 2023 Author responded Author comments - Rui Hou
Resubmission - Version 4
25 Jul 2023 Submitted Manuscript version 4
14 Aug 2023 Author responded Author comments - Rui Hou
Resubmission - Version 5
14 Aug 2023 Submitted Manuscript version 5
24 Aug 2023 Author responded Author comments - Rui Hou
Resubmission - Version 6
24 Aug 2023 Submitted Manuscript version 6
3 Sep 2023 Author responded Author comments - Rui Hou
Resubmission - Version 7
3 Sep 2023 Submitted Manuscript version 7
17 Sep 2023 Reviewed Reviewer Report
2 Oct 2023 Reviewed Reviewer Report - Dhifaf Sarhan
9 Oct 2023 Author responded Author comments - Rui Hou
Resubmission - Version 8
9 Oct 2023 Submitted Manuscript version 8
10 Oct 2023 Author responded Author comments - Rui Hou
Resubmission - Version 9
10 Oct 2023 Submitted Manuscript version 9
15 Oct 2023 Reviewed Reviewer Report - Dhifaf Sarhan
31 Oct 2023 Reviewed Reviewer Report
1 Dec 2023 Author responded Author comments - Rui Hou
Resubmission - Version 10
1 Dec 2023 Submitted Manuscript version 10
20 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 11
Submitted Manuscript version 11
Publishing
28 Dec 2023 Editorially accepted
23 Jan 2024 Article published 10.1186/s12885-023-11806-1

You can find further information about peer review here.

Back to article page